RM

REMSleep Holdings IncOOTC RMSL Stock Report

Last reporting period 30 Jun, 2024

Updated 14 Nov, 2024

Last price

Market cap $B

0.015

Micro

Exchange

OOTC - OTC

RMSL Stock Analysis

RM

Uncovered

REMSleep Holdings Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-49/100

Low score

Market cap $B

0.015

Dividend yield

Shares outstanding

1 461.62 B

RemSleep Holdings, Inc. engages in the design and manufacture of medical devices and products for the treatment of sleep apnea and other respiratory conditions. The company is headquartered in Clearwater, Florida. The company went IPO on 2008-12-15. The firm develops DeltaWave CPAP interface (the DeltaWave), which is a device to treat patients with sleep apnea. The patent-pending DeltaWave product is a nasal-pillows type interface is specifically designed with airflow characteristics to enable patients with sleep apnea to breathe normally. The Company’s product is manufactured by mold makers. The company has molds made in China. The Company’s target market includes sleep product distributors, which can distribute its products; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals; and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.

View Section: Eyestock Rating